Cardinal “Fee-For-Service” Model Includes Rx Product Integrity Payments

Cardinal expects drug manufacturers to pay the drug wholesaler for maintaining "product integrity" as part of its new "fee-for-service" business model

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet